1. Adverse events; vital signs; laboratory safety tests; 12-lead electrocardiograms; physical examinations following a single or multiple oral doses of MK-44822. Cmax; Tmax; t1/2; AUC0-12; AUC0-last and AUC0-inf of N-hydroxycytidine in plasma following a single oral dose of MK-44823. Ctrough; Cmax; Tmax; t1/2; AUC0-tau; accumulation ratio for Cmax and AUC0-tau of N-hydroxycytidine following multiple oral doses of MK-4482

1. Adverse events; vital signs; laboratory safety tests; 12-lead electrocardiograms; physical examinations following a single or multiple oral doses of MK-44822. Cmax; Tmax; t1/2; AUC0-12; AUC0-last and AUC0-inf of N-hydroxycytidine in plasma following a single oral dose of MK-44823. Ctrough; Cmax; Tmax; t1/2; AUC0-tau; accumulation ratio for Cmax and AUC0-tau of N-hydroxycytidine following multiple oral doses of MK-4482